Genotype
|
Polymorphism
|
No. of patients
|
PFS (Mo)
|
P*
|
OS (Mo)
|
P*
|
---|
−2578C/A
|
CC
|
116
|
4.9
|
0.676
|
12.8
|
0.423
|
|
CA
|
63
|
3.9
| |
14.4
| |
|
AA
|
11
|
3.0
| |
11.5
| |
−2489C/T
|
CC
|
116
|
4.9
|
0.249
|
12.8
|
0.462
|
|
CT
|
60
|
4.0
| |
14.4
| |
|
TT
|
14
|
2.9
| |
11.5
| |
−1498 T/C
|
TT
|
116
|
4.9
|
0.647
|
12.8
|
0.440
|
|
TC
|
61
|
3.9
| |
13.7
| |
|
CC
|
13
|
3.0
| |
11.8
| |
−634 G/C
|
GG
|
54
|
3.5
|
0.043
|
13.1
|
0.407
|
|
GC
|
93
|
4.8
| |
14.4
| |
|
CC
|
43
|
4.9
| |
11.5
| |
+936C/T
|
CC
|
135
|
4.5
|
0.925
|
13.1
|
0.711
|
|
CT
|
45
|
4.7
| |
11.9
| |
|
TT
|
10
|
3.9
| |
11.9
| |
+1612 G/A
|
GG
|
139
|
4.4
|
0.448
|
12.8
|
0.644
|
|
GA
|
47
|
5.0
| |
14.4
| |
|
AA
|
4
|
2.1
| |
10.6
| |
- *by log-rank test.
- PFS: progression free survival, Mo: months, OS: overall survival.